This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Kabushiki Kaisha Yakult Honsha, National Cerebral and Cardiovascular Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 215 
1 out of 51 
Years Active: 2025
Title: Motofumi Kumazoe: Innovator in Tumor Immunotherapy
Introduction
Motofumi Kumazoe is a notable inventor based in Suita, Japan. He has made significant contributions to the field of tumor immunotherapy, particularly through his innovative patent that enhances immune response.
Latest Patents
Kumazoe holds a patent for an "Antitumor effect potentiator." This invention serves as an activator suitable for immune response in tumor immunotherapy using an immune checkpoint inhibitor. The agent is designed to potentiate the antitumor effect of an immune checkpoint inhibitor and may include probiotics and prebiotics as active ingredients.
Career Highlights
Throughout his career, Kumazoe has worked with esteemed organizations such as the National Cerebral and Cardiovascular Center and Yakult Honsha Co., Ltd. His work in these institutions has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Kumazoe has collaborated with notable colleagues, including Kenji Kangawa and Takashi Nojiri. Their combined expertise has contributed to advancements in immunotherapy and related research.
Conclusion
Motofumi Kumazoe's contributions to tumor immunotherapy through his patent and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile